双门手术减少了心力衰竭的复发,与高度多膜狭窄症中单独的TAVR相比
Marco Tagliafierro1, Rahul Kanade1, Darina Kirilina1
1Columbia University Irving Medical Center, New York, NY, United States.
概括
治疗严重的大动脉狭窄症 (AS) 和 mitrales 狭窄症 (MS) 仅用跨导管大动脉置换 (TAVR) 增加了心力衰竭的再入院率. 双门手术 (DVS) 最好用于那些能容忍它的患者.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 同时发生的严重大动脉狭窄症 (AS) 和中度/严重的额头狭窄症 (MS) 存在复杂的治疗挑战.
- 双门手术 (DVS) 是黄金标准,但具有很高的手术风险.
- 隔离式透气管大动脉置换 (I-TAVR) 是用于高风险患者,由于缺乏透气管 mitra 狭窄装置,但其长期疗效尚不清楚.
研究的目的:
- 为了比较严重AS和中度/严重MS患者的DVS与I-TAVR的结果.
- 为了确定这些干预后与复发性心力衰竭 (HF) 再入院相关的因素.
主要方法:
- 在2015-2025年期间接受治疗的严重AS和中度/严重MS患者的回顾性分析.
- 患者被分为DVS和I-TAVR组.
- 使用倾向性得分匹配和多变量分析来评估HF再录取的结果和风险因素.
主要成果:
- 与DVS相比,I-TAVR与心力衰竭 (HF) 再住院率显著更高,即使在倾向性得分匹配后也是如此.
- 两组之间在短期到中期全因死亡率或中风方面没有发现显著差异.
- I-TAVR被确定为HF再住院的独立风险因素.
结论:
- 在患有严重并发性AS和MS的患者中,I-TAVR是HF再入院的独立预测因子.
- 虽然I-TAVR是高风险个体的可行选择,但DVS应该优先考虑那些能接受手术的患者.
- 可能需要进一步的研究来优化对这种复杂的患者群体的管理策略.
关键词:
多膜性疾病是多膜性疾病.塔维 (Tavi) 是一个古老的城市.双门手术是一项双门手术.心脏衰竭是因为心脏衰竭.中度至重度的 mitra 狭窄症.再接纳是指重新接纳的情况.严重的大动脉狭窄症通过导管更换大动脉门.更多相关视频
相关概念视频
Mitral Stenosis III: Medical Management
345
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
345
Aortic Regurgitation III: Medical Management
499
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
499
Mitral Regurgitation III: Medical Management
427
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
427
Heart Valves
12.7K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
12.7K
Mitral Stenosis IV: Nursing Management
313
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
313
Heart Failure VI: Adjunct Therapies
442
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442


